Doximity Inc. (DOCS)
AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Company Description
Doximity, Inc. operates a cloud-based digital platform for medical professionals in the United States.
The company's platform provides its members with tools built for medical professionals, enabling them to collaborate with their colleagues, coordinate patient care, conduct virtual patient visits, stay up to date with the latest medical news and research, and manage their careers.
It primarily serves pharmaceutical manufacturers and healthcare systems.
The company was formerly known as 3MD Communications, Inc. and changed its name to Doximity, Inc. in June 2010.
Doximity, Inc. was incorporated in 2010 and is headquartered in San Francisco, California.
Country | United States |
IPO Date | Jun 24, 2021 |
Industry | Medical - Healthcare Information Services |
Sector | Healthcare |
Employees | 827 |
CEO | Jeffrey A. Tangney |
Contact Details
Address: 500, 3rd Street San Francisco, California United States | |
Website | https://www.doximity.com |
Stock Details
Ticker Symbol | DOCS |
Exchange | NYSE |
Fiscal Year | April - March |
Reporting Currency | USD |
CIK Code | 0001516513 |
CUSIP Number | 26622P107 |
ISIN Number | US26622P1075 |
Employer ID | 27-2485512 |
SIC Code | 7371 |
Key Executives
Name | Position |
---|---|
Jeffrey A. Tangney | Co-Founder, Chief Executive Officer & Chairperson |
Anna Bryson | Chief Financial Officer |
Jey Balachandran | Chief Technology Officer |
Bruno Miranda | Senior Vice President of Engineering |
Craig A. Overpeck | Senior Vice President of Commercial Operations |
Dr. Nate Gross M.D. | Co-Founder & Chief Strategy Officer |
Jennifer W. Chaloemtiarana J.D. | General Counsel & Corporate Secretary |
Joel Davis | Senior Vice President of Product |
Perry Scott Gold | Head of Investor Relations |
Shari Buck | Co-founder and SVice President People & Ops |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Nov 15, 2024 | 4 | Filing |
Nov 15, 2024 | 4 | Filing |
Nov 14, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
Nov 14, 2024 | 4 | Filing |
Nov 14, 2024 | 4 | Filing |
Nov 14, 2024 | SC 13G | Statement of acquisition of beneficial ownership b... |
Nov 12, 2024 | SC 13G | Statement of acquisition of beneficial ownership b... |
Nov 08, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
Nov 07, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial own... |
Nov 07, 2024 | 10-Q | Quarterly Report |